Analyst Predictions and Insights for Bath & Body Works
Bath & Body Works, Inc. (NYSE: BBWI) is set to announce its fourth-quarter financial results soon. With the earnings report expected to be released early, many eyes are on the analysts who are revising their forecasts as the date approaches.
What Analysts Anticipate
Industry analysts are projecting that the leading personal care retailer will report earnings per share at about $2.04. This figure reflects a slight decline from the $2.06 recorded in the previous year, indicating a minor yet notable shift in the company’s profit margins.
In terms of revenue, forecasts suggest that Bath & Body Works will bring in approximately $2.78 billion, down from last year’s $2.91 billion. This anticipated decrease may raise concerns among investors regarding the company's performance and growth trajectory in an evolving market.
Dividends and Stock Performance
On February 7, Bath & Body Works declared its regular quarterly dividend of 20 cents per share. This payment is scheduled for March 7 and is aimed at shareholders recorded as of the close on February 21. Regular dividend payouts are often viewed positively by investors, signaling the company’s commitment to returning value to its shareholders.
The company’s stock has experienced fluctuations leading up to the earnings call. Recently, shares gained 1.1%, closing at $41.08, illustrating some investor optimism in spite of the anticipated earnings dip.
Expert Ratings and Analyst Updates
As the earnings report date nears, several prominent analysts have revised their ratings for Bath & Body Works, reflecting their evolving outlook on the company’s prospects. Here’s a brief overview of recent changes made by the most accurate analysts:
- On February 25, 2025, Olivia Tong from Raymond James affirmed an Outperform rating, raising the price target from $42 to $46, demonstrating confidence in Bath & Body Works’ potential.
- In a notable upgrade, Adrienne Yih from Barclays moved from an Underweight to an Equal-Weight rating, raising her price target from $34 to $43 as of February 24, 2025.
- JP Morgan’s Matthew Boss provided some positive news by raising the stock rating from Neutral to Overweight, with an increased price target moving from $41 to $47 on February 18, 2025.
- Wells Fargo analyst Ike Boruchow escalated his recommendation from Equal-Weight to Overweight while also enhancing the price target from $42 to $48 as of January 10, 2025.
- Lastly, TD Cowen’s Jonna Kim maintains a Buy rating, raising the price target from $42 to $48 on December 12, 2024, signaling a consistent bullish outlook.
Investor Considerations
As potential investors consider entering the market with BBWI stock, it’s essential to examine these revised forecasts and analyst ratings further. Understanding the broader consumer goods market trends, especially in personal care, can provide insights into Bath & Body Works’ performance against its peers.
Market analysts emphasize that while short-term fluctuations are common, focusing on long-term strategies will serve investors well as Bath & Body Works navigates its upcoming financial disclosures. The company’s loyal customer base and innovative product lines may continue to provide viability even in a challenging retail landscape.
Frequently Asked Questions
What are analysts predicting for Bath & Body Works' upcoming earnings?
Analysts expect that Bath & Body Works will report earnings of approximately $2.04 per share.
How did Bath & Body Works stock perform before the earnings call?
The stock gained 1.1%, closing at $41.08 prior to the announcement of the fourth-quarter earnings.
When will Bath & Body Works announce its dividend?
The upcoming dividend will be payable on March 7 to shareholders recorded by February 21.
What recent upgrades have analysts made for Bath & Body Works?
Analysts have made various upgrades, with price targets set between $43 and $48 based on recent evaluations.
Why is the upcoming earnings report significant for investors?
The report will provide insight into the company's financial health and could affect stock performance going forward, crucial for determining investment strategies.
